OBJECTIVES: We measured HIV care outcomes of transgender persons, who have high HIV infection rates but are rarely distinguished from men who have sex with men (MSM) in HIV surveillance systems. METHODS: New York City's surveillance registry includes HIV diagnoses since 2000 and HIV laboratory test results for transgender persons since 2005. We determined immunological status at diagnosis, delayed linkage to care, and nonachievement of viral suppression 1 year after diagnosis for transgender persons diagnosed with HIV in 2006 to 2011 and compared transgender women with MSM. RESULTS: In 2006 to 2011, 264 of 23 805 persons diagnosed with HIV were transgender (1%): 98% transgender women and 2% transgender men. Compared with MSM, transgender women had similar CD4 counts at diagnosis and rates of concurrent HIV/AIDS and delayed linkage to care but increased odds of not achieving suppression (adjusted odds ratio = 1.56; 95% confidence interval = 1.13, 2.16). CONCLUSIONS: Compared with MSM, transgender women in New York City had similar immunological status at diagnosis but lagged in achieving viral suppression. To provide appropriate assistance along the HIV care continuum, HIV care providers should accurately identify transgender persons.
OBJECTIVES: We measured HIV care outcomes of transgender persons, who have high HIV infection rates but are rarely distinguished from men who have sex with men (MSM) in HIV surveillance systems. METHODS: New York City's surveillance registry includes HIV diagnoses since 2000 and HIV laboratory test results for transgender persons since 2005. We determined immunological status at diagnosis, delayed linkage to care, and nonachievement of viral suppression 1 year after diagnosis for transgender persons diagnosed with HIV in 2006 to 2011 and compared transgender women with MSM. RESULTS: In 2006 to 2011, 264 of 23 805 persons diagnosed with HIV were transgender (1%): 98% transgender women and 2% transgender men. Compared with MSM, transgender women had similar CD4 counts at diagnosis and rates of concurrent HIV/AIDS and delayed linkage to care but increased odds of not achieving suppression (adjusted odds ratio = 1.56; 95% confidence interval = 1.13, 2.16). CONCLUSIONS: Compared with MSM, transgender women in New York City had similar immunological status at diagnosis but lagged in achieving viral suppression. To provide appropriate assistance along the HIV care continuum, HIV care providers should accurately identify transgender persons.
Authors: Ellen W Wiewel; Sarah L Braunstein; Qiang Xia; Colin W Shepard; Lucia V Torian Journal: J Acquir Immune Defic Syndr Date: 2015-02-01 Impact factor: 3.731
Authors: Rita M Melendez; Theresa A Exner; Anke A Ehrhardt; Brian Dodge; Robert H Remien; Mary-Jane Rotheram-Borus; Marguerita Lightfoot; Daniel Hong Journal: Am J Public Health Date: 2005-08-30 Impact factor: 9.308
Authors: Edward M Gardner; Margaret P McLees; John F Steiner; Carlos Del Rio; William J Burman Journal: Clin Infect Dis Date: 2011-03-15 Impact factor: 9.079
Authors: Ansley Lemons; Linda Beer; Teresa Finlayson; Donna Hubbard McCree; Daniel Lentine; R Luke Shouse Journal: Am J Public Health Date: 2018-07 Impact factor: 9.308
Authors: Pablo D Radusky; Ines Aristegui; Lissa N Mandell; Emanuel Dell'Isola; Virginia Zalazar; Nadir Cardozo; María L Alcaide; Stephen M Weiss; Deborah L Jones; Omar Sued Journal: Int J Behav Med Date: 2021-05-06
Authors: Pablo D Radusky; Virginia Zalazar; Nadir Cardozo; Solange Fabian; Mariana Duarte; Claudia Frola; Pedro Cahn; Omar Sued; Inés Aristegui Journal: Transgend Health Date: 2020-12-11
Authors: Emilia M Jalil; Erin C Wilson; Paula M Luz; Luciane Velasque; Ronaldo I Moreira; Cristiane V Castro; Laylla Monteiro; Ana Cristina F Garcia; Sandra W Cardoso; Lara E Coelho; Willi McFarland; Albert Y Liu; Valdilea G Veloso; Susan Buchbinder; Beatriz Grinsztejn Journal: J Int AIDS Soc Date: 2017-09-19 Impact factor: 5.396